IMPAIRED PRENATAL AND POSTNATAL-GROWTH IN DUTCH PATIENTS WITH PHENYLKETONURIA

被引:54
作者
VERKERK, PH
VANSPRONSEN, FJ
SMIT, GPA
SENGERS, RCA
机构
[1] UNIV GRONINGEN HOSP, DEPT PAEDIAT, GRONINGEN, NETHERLANDS
[2] UNIV NIJMEGEN HOSP, DEPT PAEDIAT, 6500 HB NIJMEGEN, NETHERLANDS
关键词
D O I
10.1136/adc.71.2.114
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective - To assess whether physical growth is affected in early treated Dutch patients with phenylketonuria (PKU). Methods - The birth weights of all 137 early detected patients with PKU born in the period from 1974 to 1988 in the Netherlands were compared with reference values. Height, head circumference, and weight were measured at the age at which treatment started (commonly about 2-3 weeks), at 6 months of age, and yearly from the child's first birthday up to the age of 10 years. These measurements were compared with reference values. Results - The adjusted birth weight in patients with PKU was 141 g (95% confidence interval (CI) 66 to 216 g) less than Dutch reference values by Kloosterman and 103 g (95% CI 9 to 196 g) less compared with the birth weight of another reference group. At the age at which treatment started, z scores of patients for height by age were -0.23 (95% CI -0.44 to -0.02) and z scores for head circumference by age were -0.25 (95% CI -0.44 to -0.06). From the age at which treatment started up to the age of 3 years z scores for height by age further decreased to -0.74 (95% confidence interval -0.93 to -0.56), after which no additional decrease occurred. In contrast, z scores for head circumference increased from -0.25 at the first visit to 0.08 (95% CI -0.14 to 0.30) at the age of 1 year, after which they remained close to zero. Weight by height was close to the expected centiles for all ages. Conclusion - Patients with PKU are growth retarded at birth and have smaller head circumferences than the normal population. In Dutch patients further growth retardation occurs in the first three years of life.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 24 条
[1]   PLASMA PHENYLALANINE AND TYROSINE LEVELS DURING THE DAY IN NORMAL FEMALE CONTROLS AND FEMALE OBLIGATE PHENYLKETONURIA HETEROZYGOTES [J].
DEGROOT, CJ ;
HOMMES, FA .
ENZYME, 1982, 28 (04) :404-407
[2]  
Herngreen WP, 1992, EUROPEAN J PUBLIC HL, V2, P117
[3]  
HOLM VA, 1979, PEDIATRICS, V63, P700
[4]  
HOLM VA, 1979, PEDIATRICS, V63, P694
[5]   ELEVATION OF PLASMA PHENYLALANINE LEVELS DURING PREGNANCIES OF WOMEN HETEROZYGOUS FOR PHENYLKETONURIA [J].
KANG, E ;
PAINE, RS .
JOURNAL OF PEDIATRICS, 1963, 63 (02) :283-+
[6]  
Kloosterman G J, 1969, Maandschr Kindergeneeskd, V37, P209
[7]  
Knox WE, 1972, METABOLIC BASIS INHE, P266
[8]   MATERNAL PHENYLKETONURIA AND HYPERPHENYLALANINEMIA - AN INTERNATIONAL SURVEY OF THE OUTCOME OF UNTREATED AND TREATED PREGNANCIES [J].
LENKE, RR ;
LEVY, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (21) :1202-1208
[9]   PHYSICAL GROWTH OF CHILDREN TREATED FOR PHENYLKETONURIA [J].
MCBURNIE, MA ;
KRONMAL, RA ;
SCHUETT, VE ;
KOCH, R ;
AZENG, CG .
ANNALS OF HUMAN BIOLOGY, 1991, 18 (04) :357-368
[10]  
Meijer W J, 1985, Ned Tijdschr Geneeskd, V129, P74